Published on 5 October 2026
Giving certain brain tumour patients radiotherapy after surgery can halve the risk of their cancer returning, a new study suggests.
Atypical meningioma is a type of brain tumour that grows back nearly 50% of the time within five years of surgery. But a new study led by experts from The Walton Centre NHS Foundation Trust the University of Liverpool suggests this risk can be reduced with radiotherapy after surgery.
This is according to results from a major international clinical trial called ROAM (Radiation versus Observation following surgical resection of Atypical Meningioma) led by Chief investigator, Professor Michael Jenkinson.
Neurosurgeon Prof Jenkinson said: “I’m proud that our team has been able to generate robust evidence that can help patients and clinicians make better-informed decisions.”
For more on this, see: Radiotherapy halves the risk of brain tumour returning after surgery - News - University of Liverpool